SEC fundamentals · as filed in 10-K FY2026, period ended May 31, 2026 · updated Sep 7, 2026
as filed in 10-K FY2026, period ended May 31, 2026 · View filings on EDGAR ↗
In its FY2026 report, NEOGEN CORP reported total assets of $3.35B, stockholders' equity of $2.09B, and revenue of $870.4M. Every figure below is taken directly from NEOGEN CORP's SEC filings: each links to the source document on EDGAR.
Revenue · FY2017–FY2026 · as reported
as of May 31, 2026 · 10-K
10-K (annual) · period ended May 31, 2026
| Revenue | $870.4M | Revenue | source ↗ |
| Net Income | -$7.9M | Net | source ↗ |
| Operating Income | -$21.6M | Operating | source ↗ |
| Gross Profit | $408.5M | Gross | source ↗ |
| Cost of Revenue | $461.9M | Cost | source ↗ |
| R&D Expense | $18.4M | Research | source ↗ |
10-K (annual) · period ended May 31, 2026
| EPS (diluted) | $-0.04 | Earnings | source ↗ |
| EPS (basic) | $-0.04 | Earnings | source ↗ |
| Shares Outstanding | 218.1M | Entity | source ↗ |
| Cash from Operations | $83.2M | Net | source ↗ |
| Cash from Financing | -$99.4M | Net | source ↗ |
| Cash from Investing | $70.5M | Net | source ↗ |
Form 4 open-market activity, last 180 days
12 of 533 annual fact-keys were materially restated between filings: what NEOGEN CORP first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail behind the counts above, plus MCP access for your own agents, across the whole SEC universe.
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.